Impact of Visceral Manipulation Versus Integrated Neuromuscular Inhibition Technique in Shoulder Impingement Syndrome

Launched by NOHA ELSERTY · Feb 15, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different treatment methods for people with shoulder impingement syndrome, which is a condition that causes pain and limits movement in the shoulder. The trial compares "Visceral Manipulation," a hands-on therapy aimed at improving how the body functions, with "Integrated Neuromuscular Inhibition Technique," which focuses on easing muscle tension. Researchers want to see how these treatments affect pain levels, the ability to move the shoulder, and overall function.

To participate in this study, individuals should have chronic pain in the upper trapezius muscle (the muscle at the back of the neck and shoulder) that has lasted more than 12 weeks and a body mass index (BMI) between 25 and 30. However, people who have had recent neck or shoulder surgeries, certain medical conditions like cancer or osteoporosis, or specific posture problems will not be eligible to join. This trial is currently not recruiting participants, but once it starts, those who qualify can expect to receive one of the two treatments and help contribute to understanding better ways to treat shoulder pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • -active myofascial trigger points in the upper trapezius muscle, and chronic Pain lasting more than 12 weeks
• • BMI between 25 and 30 Kg/m².
• Exclusion Criteria:
• • a previous fracture in the cervical spine or shoulder surgery
• • acute inflammatory condition.
• • Malignant tumor.
• • Multiple osteophytes.
• • Cervical posture abnormalities.
• • Osteoporosis.